|
1.
|
Filler G, Bökenkamp A, Hofmann W, Le
Bricon T, Martinez-Brü C and Grubb A: Cystatin C as a marker of GFR
- history, indications, and future research. Clin Biochem. 38:1–8.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Newman DJ: Cystatin C. Ann Clin Biochem.
39:89–104. 2002. View Article : Google Scholar
|
|
3.
|
Chew JS, Saleem M, Florkowski CM and
George PM: Cystatin C - a paradigm of evidence based laboratory
medicine. Clin Biochem Rev. 29:47–62. 2008.PubMed/NCBI
|
|
4.
|
Ando N, Iizuka T, Ide H, et al: Surgery
plus chemotherapy compared with surgery alone for localized
squamous cell carcinoma of the thoracic esophagus: a Japan Clinical
Oncology Group Study-JCOG9204. J Clin Oncol. 21:4592–4596. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Ando N, Kato H, Igaki H, et al: A
randomized trial comparing postoperative adjuvant chemotherapy with
cisplatin and 5-fluorouracil versus preoperative chemotherapy for
localized advanced squamous cell carcinoma of the thoracic
esophagus (JCOG9907). Ann Surg Oncol. 19:68–74. 2012. View Article : Google Scholar
|
|
6.
|
American Society of Clinical Oncology;
Kris MG, Hesketh PJ, Somerfield MR, et al: American Society of
Clinical Oncology guideline for antiemetics in oncology: update
2006. J Clin Oncol. 24:2932–2947. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Kume M, Yasui H, Yoshikawa Y, et al:
Transient elevation of serum cystatin C concentrations during
perioperative cisplatin-based chemotherapy in esophageal cancer
patients. Cancer Chemother Pharmacol. 69:1537–1544. 2012.
View Article : Google Scholar
|
|
8.
|
Miki I, Tamura T, Nakamura T, et al:
Circadian variability of pharmacokinetics of 5-fluorouracil and
CLOCK T3111C genetic polymorphism in patients with esophageal
carcinoma. Ther Drug Monit. 27:369–374. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Nakade S, Ohno T, Kitagawa J, et al:
Population pharmacokinetics of aprepitant and dexamethasone in the
prevention of chemotherapy-induced nausea and vomiting. Cancer
Chemother Pharmacol. 63:75–83. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Takara K, Fujita M, Minegaki T, et al:
Treatment schedule-dependent effect of 5-fluorouracil and platinum
derivatives in colorectal cancer cells. Eur J Pharm Sci.
45:272–281. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Bjarnadóttir M, Grubb A and Olafsson I:
Promoter-mediated, dexamethasone-induced increase in cystatin C
production by HeLa cells. Scand J Clin Lab Invest. 55:617–623.
1995.PubMed/NCBI
|
|
12.
|
Zhang C, Beckermann B, Kallifatidis G, et
al: Corticosteroids induce chemotherapy resistance in the majority
of tumour cells from bone, brain, breast, cervix, melanoma and
neuroblastoma. Int J Oncol. 29:1295–1301. 2006.
|
|
13.
|
Abrahamson M, Olafsson I, Palsdottir A, et
al: Structure and expression of the human cystatin C gene. Biochem
J. 268:287–294. 1990.PubMed/NCBI
|
|
14.
|
Abrahamson M, Barrett AJ, Salvesen G and
Grubb A: Isolation of six cysteine proteinase inhibitors from human
urine. Their physicochemical and enzyme kinetic properties and
concentrations in biological fluids. J Biol Chem. 261:11282–11289.
1986.
|
|
15.
|
Grzonka Z, Jankowska E, Kasprzykowski F,
et al: Structural studies of cysteine proteases and their
inhibitors. Acta Biochim Pol. 48:1–20. 2001.PubMed/NCBI
|
|
16.
|
Bijnsdorp IV, Peters GJ, Temmink OH,
Fukushima M and Kruyt FA: Differential activation of cell death and
autophagy results in an increased cytotoxic potential for
trifluorothymidine compared to 5-fluorouracil in colon cancer
cells. Int J Cancer. 126:2457–2468. 2010.
|
|
17.
|
Mathew R, Karantza-Wadsworth V and White
E: Role of autophagy in cancer. Nat Rev Cancer. 7:961–967. 2007.
View Article : Google Scholar
|
|
18.
|
Tizon B, Sahoo S, Yu H, et al: Induction
of autophagy by cystatin C: a mechanism that protects murine
primary cortical neurons and neuronal cell lines. PLoS One.
5:e98192010. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
O’Donovan TR, O’Sullivan GC and McKenna
SL: Induction of autophagy by drug-resistant esophageal cancer
cells promotes their survival and recovery following treatment with
chemotherapeutics. Autophagy. 7:509–524. 2011.
|
|
20.
|
Balsalobre A, Brown SA, Marcacci L, et al:
Resetting of circadian time in peripheral tissues by glucocorticoid
signaling. Science. 289:2344–2347. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Terazono H, Hamdan A, Matsunaga N, et al:
Modulatory effects of 5-fluorouracil on the rhythmic expression of
circadian clock genes: a possible mechanism of chemotherapy-induced
circadian rhythm disturbances. Biochem Pharmacol. 75:1616–1622.
2008. View Article : Google Scholar
|
